COBRED aims at discovering colon cancer and breast cancer biomarkers for patient follow-up (monitoring markers) by exploiting the capacity of 3 state-of-the-art high-throughput technologies in an integrated systems biology approach. The goal is to identify biomarker candidates (metabolites, proteins, PBL derived mRNAs) capable to detect and assess the status of minimal residual disease, metastases and recurrence after surgery and chemotherapy. (See Goals).
COBRED is an EU FP6 funded 3-year Specific Targeted Research Project (STREP)
COBRED will hold its Satellite Symposium embedded in the Eurocancer 2010 Meeting in the convention Center Palais des Congres de Paris - 2, place de la Porte Maillot - 75017 Paris
Further information regarding the event can be found by visiting www.eurocancer.com You can also download a copy of the workshop survival pack including the program here.